Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
9913662
Reference Type
Journal Article
Title
Experimental mesangial proliferative glomerulopathy
Author(s)
Lawler, W
Year
1981
Is Peer Reviewed?
Yes
Journal
Journal of Pathology
ISSN:
0022-3417
EISSN:
1096-9896
Volume
133
Issue
2
Page Numbers
107-122
Language
English
PMID
7009814
DOI
10.1002/path.1711330203
Abstract
A mesangial proliferative glomerulopathy was induced in rabbits by repeated, intravenous fixed doses of heterologous (porcine) thyroglobulin. Twenty-five (75.8 per cent) of 33 rabbits showed mesangial proliferation with normal peripheral capillary basement membranes. Immunofluorescence revealed mesangial deposits of host immunoglobulins in 16 (59 per cent.) of 27 rabbits, and 6 (32 per cent.) of 19 showed similar thyroglobulin deposition. Ultrastructurally, irregular, ill defined areas of increased electron density were seen in the mesangial matrix in 14 (86 per cent.) of the 16 examined, and in eight (50 per cent.), discrete, granular intramesangial electron dense deposits were also identified. Results indicate that chronic immunisation with fixed doses of heterologous thyroglobulin is a reliable and reproducible method for inducing an experimental mesangial proliferative glomerulopathy in rabbits. This glomerulopathy is very similar morphologically to humans primary mesangial proliferative glomerulonephritis, particularly when the latter is associated with IgM deposition.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity